IQVIA Holdings, Inc. stock is up 18.23% since 30 days ago. The next earnings date is Feb 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 72.73% of the previous 10 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 86% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
31 Oct 19:27 | 17 May, 2024 | 175.00 | 0 | ||
31 Oct 19:37 | 19 Jan, 2024 | 185.00 | 12 | ||
02 Nov 13:42 | 19 Jan, 2024 | 185.00 | 44 | ||
02 Nov 16:38 | 16 Feb, 2024 | 180.00 | 5 | ||
03 Nov 17:07 | 17 Nov, 2023 | 100.00 | 0 | ||
06 Nov 14:52 | 17 Nov, 2023 | 185.00 | 515 | ||
14 Nov 17:15 | 15 Dec, 2023 | 200.00 | 269 | ||
17 Nov 14:38 | 15 Dec, 2023 | 195.00 | 91 | ||
17 Nov 15:54 | 17 Nov, 2023 | 100.00 | 4 | ||
17 Nov 16:24 | 17 Nov, 2023 | 195.00 | 444 |
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.